108 related articles for article (PubMed ID: 7694637)
1. Identification and characterization of genes differentially expressed in meningiomas.
Murphy M; Pykett MJ; Harnish P; Zang KD; George DL
Cell Growth Differ; 1993 Sep; 4(9):715-22. PubMed ID: 7694637
[TBL] [Abstract][Full Text] [Related]
2. Identification of a microsatellite instability phenotype in meningiomas.
Pykett MJ; Murphy M; Harnish PR; George DL
Cancer Res; 1994 Dec; 54(24):6340-3. PubMed ID: 7987826
[TBL] [Abstract][Full Text] [Related]
3. Expression of the tumor suppressor genes NF2, 4.1B, and TSLC1 in canine meningiomas.
Dickinson PJ; Surace EI; Cambell M; Higgins RJ; Leutenegger CM; Bollen AW; LeCouteur RA; Gutmann DH
Vet Pathol; 2009 Sep; 46(5):884-92. PubMed ID: 19429976
[TBL] [Abstract][Full Text] [Related]
4. Meningiomas and schwannomas: molecular subgroup classification found by expression arrays.
Martinez-Glez V; Franco-Hernandez C; Alvarez L; De Campos JM; Isla A; Vaquero J; Lassaletta L; Casartelli C; Rey JA
Int J Oncol; 2009 Feb; 34(2):493-504. PubMed ID: 19148485
[TBL] [Abstract][Full Text] [Related]
5. Microarray-based analysis of spinal versus intracranial meningiomas: different clinical, biological, and genetic characteristics associated with distinct patterns of gene expression.
Sayagués JM; Tabernero MD; Maíllo A; Trelles O; Espinosa AB; Sarasquete ME; Merino M; Rasillo A; Vera JF; Santos-Briz A; de Alava E; Garcia-Macias MC; Orfao A
J Neuropathol Exp Neurol; 2006 May; 65(5):445-54. PubMed ID: 16772868
[TBL] [Abstract][Full Text] [Related]
6. Molecular genetics of meningiomas: from basic research to potential clinical applications.
Simon M; Boström JP; Hartmann C
Neurosurgery; 2007 May; 60(5):787-98; discussion 787-98. PubMed ID: 17460514
[TBL] [Abstract][Full Text] [Related]
7. HIN-1, a putative cytokine highly expressed in normal but not cancerous mammary epithelial cells.
Krop IE; Sgroi D; Porter DA; Lunetta KL; LeVangie R; Seth P; Kaelin CM; Rhei E; Bosenberg M; Schnitt S; Marks JR; Pagon Z; Belina D; Razumovic J; Polyak K
Proc Natl Acad Sci U S A; 2001 Aug; 98(17):9796-801. PubMed ID: 11481438
[TBL] [Abstract][Full Text] [Related]
8. Down-regulation of T1A12/mac25, a novel insulin-like growth factor binding protein related gene, is associated with disease progression in breast carcinomas.
Burger AM; Zhang X; Li H; Ostrowski JL; Beatty B; Venanzoni M; Papas T; Seth A
Oncogene; 1998 May; 16(19):2459-67. PubMed ID: 9627112
[TBL] [Abstract][Full Text] [Related]
9. Neurofibromatosis type 2 and von Hippel-Lindau disease: from gene cloning to function.
Kley N; Whaley J; Seizinger BR
Glia; 1995 Nov; 15(3):297-307. PubMed ID: 8586465
[TBL] [Abstract][Full Text] [Related]
10. Integrative genomic analysis identifies NDRG2 as a candidate tumor suppressor gene frequently inactivated in clinically aggressive meningioma.
Lusis EA; Watson MA; Chicoine MR; Lyman M; Roerig P; Reifenberger G; Gutmann DH; Perry A
Cancer Res; 2005 Aug; 65(16):7121-6. PubMed ID: 16103061
[TBL] [Abstract][Full Text] [Related]
11. Evidence for the complete inactivation of the NF2 gene in the majority of sporadic meningiomas.
Ruttledge MH; Sarrazin J; Rangaratnam S; Phelan CM; Twist E; Merel P; Delattre O; Thomas G; Nordenskjöld M; Collins VP
Nat Genet; 1994 Feb; 6(2):180-4. PubMed ID: 8162072
[TBL] [Abstract][Full Text] [Related]
12. Identification of a novel serine protease-like gene, the expression of which is down-regulated during breast cancer progression.
Liu XL; Wazer DE; Watanabe K; Band V
Cancer Res; 1996 Jul; 56(14):3371-9. PubMed ID: 8764136
[TBL] [Abstract][Full Text] [Related]
13. Effects of estrogen on global gene expression: identification of novel targets of estrogen action.
Charpentier AH; Bednarek AK; Daniel RL; Hawkins KA; Laflin KJ; Gaddis S; MacLeod MC; Aldaz CM
Cancer Res; 2000 Nov; 60(21):5977-83. PubMed ID: 11085516
[TBL] [Abstract][Full Text] [Related]
14. Cancer-testis antigens and ING1 tumor suppressor gene product are breast cancer antigens: characterization of tissue-specific ING1 transcripts and a homologue gene.
Jäger D; Stockert E; Scanlan MJ; Güre AO; Jäger E; Knuth A; Old LJ; Chen YT
Cancer Res; 1999 Dec; 59(24):6197-204. PubMed ID: 10626813
[TBL] [Abstract][Full Text] [Related]
15. Expression of alternative transcripts of ferroportin-1 during human erythroid differentiation.
Cianetti L; Segnalini P; Calzolari A; Morsilli O; Felicetti F; Ramoni C; Gabbianelli M; Testa U; Sposi NM
Haematologica; 2005 Dec; 90(12):1595-606. PubMed ID: 16330432
[TBL] [Abstract][Full Text] [Related]
16. Identification of genes (SPON2 and C20orf2) differentially expressed between cancerous and noncancerous lung cells by mRNA differential display.
Manda R; Kohno T; Matsuno Y; Takenoshita S; Kuwano H; Yokota J
Genomics; 1999 Oct; 61(1):5-14. PubMed ID: 10512675
[TBL] [Abstract][Full Text] [Related]
17. PDZK1 and GREB1 are estrogen-regulated genes expressed in hormone-responsive breast cancer.
Ghosh MG; Thompson DA; Weigel RJ
Cancer Res; 2000 Nov; 60(22):6367-75. PubMed ID: 11103799
[TBL] [Abstract][Full Text] [Related]
18. Quantitative analysis of neurofibromatosis type 2 gene transcripts in meningiomas supports the concept of distinct molecular variants.
Wellenreuther R; Waha A; Vogel Y; Lenartz D; Schramm J; Wiestler OD; von Deimling A
Lab Invest; 1997 Dec; 77(6):601-6. PubMed ID: 9426397
[TBL] [Abstract][Full Text] [Related]
19. Identification of new members of the Gas2 and Ras families in the 22q12 chromosome region.
Zucman-Rossi J; Legoix P; Thomas G
Genomics; 1996 Dec; 38(3):247-54. PubMed ID: 8975699
[TBL] [Abstract][Full Text] [Related]
20. Mutational analysis of the DAL-1/4.1B tumour-suppressor gene locus in meningiomas.
Martinez-Glez V; Bello MJ; Franco-Hernandez C; De Campos JM; Isla A; Vaquero J; Rey JA
Int J Mol Med; 2005 Oct; 16(4):771-4. PubMed ID: 16142420
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
